All articles tagged with #neuralink
Elon Musk has built a sprawling network of companies—from SpaceX and Tesla to Neuralink and The Boring Company—driving his wealth largely through large stakes in SpaceX and Tesla as their valuations surged, while expanding into Starlink and AI with ambitious but not always profitable bets.
A concise overview of Elon Musk’s expansive portfolio—from SpaceX and Tesla to Neuralink and The Boring Company—highlighting Neuralink’s brain‑computer implant trials (21 participants as of January), The Boring Company’s Vegas Loop and international tunnel ambitions amid safety pushback, and Musk’s broader tech footprint including PayPal/X Corp., illustrating his influence across space, automotive tech, neurotech, and underground transport.
The Verge argues Neuralink is pivoting from motor-control BCIs to speech-based BCIs, acknowledging that turning thought into spoken words may offer greater real-world impact than cursor control. While competitors have moved faster on speech decoding and Neuralink has begun speech-restoration trials in the UAE and the US, commercialization remains uncertain. The piece also frames the broader debate between augmentation and medical-use BCIs, noting market size limits and insurance hurdles, and questions whether speech BCIs will outpace motor BCIs in reaching patients.
Neuralink, led by Elon Musk, is at a crossroads between developing technology to help people with disabilities and pursuing broader ambitions like AI integration and potential future AI conflicts, with recent leadership moves fueling questions about its true priorities.
Elon Musk announced that Neuralink plans to significantly increase production of brain-chip implants in 2026, with an almost fully automated surgical procedure to implant the devices, aiming to help patients with neurological conditions and potentially merge human consciousness with AI.
Science Corporation, founded by ex-Neuralink president Max Hodak, is developing a portable, cost-effective organ perfusion system to extend the viability of organs outside the body, aiming to improve transplant outcomes and reduce costs compared to current bulky and expensive systems.
Eighteen months after receiving Neuralink's brain chip, paralyzed man Noland Arbaugh has regained significant independence, using the device to interact with digital environments and pursue new educational and speaking opportunities, highlighting the potential of brain-computer interfaces to transform lives and raise profound ethical questions.
Neuralink, founded by Elon Musk, is developing a brain implant that translates thoughts into text, initially aimed at helping speech-impaired individuals, with future plans for healthy users, raising ethical questions about human enhancement and technological integration. Clinical trials are set to evaluate safety and efficacy, while the technology sparks debates on the boundaries of human augmentation.
Noland Arbaugh, the first person implanted with Elon Musk's Neuralink brain chip, reports significant improvements in autonomy and daily life, controlling devices with his mind and pursuing education and entrepreneurship, marking a major milestone in neural technology and its potential to restore function for paralysis and neurological conditions.
Noland Arbaugh, the first participant in Neuralink's experimental brain chip study, has experienced a transformative change in his life, gaining the ability to control devices with his mind, which has significantly improved his autonomy and quality of life. Neuralink's high-electrode, wireless brain-computer interface is advancing clinical trials aimed at helping those with paralysis or ALS, with Arbaugh now actively studying, working, and engaging in new pursuits thanks to the device.
The article details the escalating rivalry between OpenAI CEO Sam Altman and Elon Musk, highlighting their personal attacks, legal battles, and competition across various tech sectors including social media, AI, and space exploration, with Altman actively challenging Musk's companies like Neuralink, Tesla, and SpaceX.
Sam Altman is co-founding a startup called Merge Labs to develop brain-to-computer interfaces, potentially competing with Elon Musk's Neuralink, with funding possibly from OpenAI's ventures team. The startup aims to revolutionize human-technology interaction and address the concept of the singularity, amid ongoing rivalry between Altman and Musk.
Sam Altman has announced plans to develop a Neuralink rival, challenging Elon Musk's Neuralink, signaling increased competition in the brain-computer interface industry.
Neuralink has launched its first European clinical trial in the UK, implanting chips in seven patients with severe paralysis to enable control of digital devices through thought, marking a significant step in brain-computer interface technology and Neuralink's global expansion.
Advancements in brain-computer interfaces (BCIs) are moving from experimental to commercial, offering new hope for people with disabilities like paralysis and speech loss. Companies like Neuralink, Precision Neuroscience, and others are developing wireless, less invasive devices that can decode brain signals to control computers, prosthetics, and even restore sensory feedback, potentially transforming lives within the next few years.